Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV

Objectives: To evaluate safety and immunogenicity of V114 [15-valent pneumococcal conjugate vaccine (PCV) containing serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F], followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23) 8 weeks later, in adults living with HI...

Full description

Saved in:
Bibliographic Details
Main Author: Mohapi L.
Other Authors: Mahidol University
Format: Article
Published: 2023
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/85018
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University